Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
AstraZeneca and Incyte enter clinical trial collaboration in early lung cancer
-
AstraZeneca and MSD rapidly advance Lynparza in Japan with a second regulatory submission
-
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
-
US FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review
-
US FDA accepts supplemental Biologics License Application for Imfinzi in locally advanced unresectable non-small cell lung cancer
-
AstraZeneca shares its comprehensive scientific approach at the World Conference on Lung Cancer 2017
-
The European Medicines Agency accepts marketing authorisation application for Imfinzi in locally-advanced unresectable non-small cell lung cancer
-
Tagrisso granted breakthrough therapy designation by US FDA for the 1st-line treatment of patients with EGFR mutation-positive non-small cell lung cancer
-
Bevespi Aerosphere demonstrates statistically significant improvement in lung function in patients with COPD
-
Bydureon EXSCEL trial demonstrates favourable cardiovascular (CV) safety profile and fewer CV events in patients with type-2 diabetes at wide range of CV risk
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
